Mindshare - Greater New York City Area since Mar 2013
Director, Trading Desk
Dow Jones - Greater New York City Area Sep 2012 - Mar 2013
Digital Account Executive
Yahoo! Jan 2011 - Aug 2012
Senior Optimization Strategist
Yahoo! Sep 2009 - Jan 2011
Optimization Specialist for Right Media
Cook Street Consulting, Inc. Jan 2006 - Mar 2009
Senior Analyst
Education:
University of Colorado at Boulder 2001 - 2006
BS, Finance
St. Mary's Academy
Honor & Awards:
Boettcher Scholar
Beta Gamma Sigma, Business Honor Society Member
Shannon Memorial Scholarship
Flanagan and Walker Scholarship
College of Business Deans List
College of Engineering Deans List
Director of Scientific Research at Pharmaceutical Development Group, Inc. (PDG)
Location:
Tampa/St. Petersburg, Florida Area
Industry:
Research
Work:
Pharmaceutical Development Group, Inc. (PDG) - Tampa/St. Petersburg, Florida Area since Oct 2011
Director of Scientific Research
University of South Florida - Health 2009 - 2012
Research Assistant Professor
Hillsborough Community College 2008 - 2011
Adjunct Professor
Case Western Reserve University 2004 - 2009
Assistant Professor
Fox Chase Cancer Center 1999 - 2003
Postdoctoral Fellow
Education:
Princeton University 1992 - 1999
PhD, Molecular Biology
Penn State University 1985 - 1989
BS, Molecular & Cellular Biology
Achieva Credit Union Clearwater, FL Dec 2012 to 2013 Assistant Branch ManagerSunTrust Bank Belmont, NC Jun 2011 to Nov 2012 FSR/Teller CoordinatorArvest Bank Lawton, OK Sep 2005 to Mar 2011First Home Bank Seminole, FL Jul 2002 to Jan 2003 Teller and New Accounts SpecialistPatriot Loan Company Hinesville, GA Jun 1995 to Oct 1997 Loan Processor and Office Manager
- Tampa FL, US Catherine Newton - Land of Lakes FL, US Catherine Patterson - Lutz FL, US Marisela Agudelo - Miami FL, US
International Classification:
A61K 31/454
US Classification:
514322
Abstract:
The present disclosure provides methods and pharmaceutical compositions for reducing the serum level of immunoglobulin IgE in an animal or human subject. It has been found that reducing or inhibiting the activity of the cannabinoid receptor CB2 leads to an increase in IgE in serum levels. Conversely, activation of the CB2 receptor by an agonist results in a reduction in IgE serum levels. The compositions and methods of the disclosure, therefore, provide a means to reduce or eliminate symptoms of immune system-related conditions resulting from IgE generation, such as an allergy, hay fever, and the like.
Isbn (Books And Publications)
Urban Patronage in Early Modern England: Corporate Boroughs, the Landed Elite, and the Crown, 1580-1640